SANOFI-AVENTIS Deutschland, GmbH ,   Germany

hypoglycemic agent - short-acting insulin analog

Solution for subcutaneous administration, 100 units / ml.

Hypoglycemic agent - short-acting insulin analog

Solution for subcutaneous administration, 100 U / ml.

Antifungal agent

Nail polish 8%.

Antitumor agent - alkaloid

Concentrate for the preparation of a solution for infusions, 40 mg / ml (complete with a solvent).

Antitumor agent.

Concentrate for the preparation of a solution for infusions of 25 mg / ml.

hypoglycemic agent - long-acting insulin analog

Solution for subcutaneous administration, 100 units / ml.

hypoglycemic agent - medium-duration insulin

Suspension for subcutaneous administration, 100 IU / ml.

hypoglycemic agent - short-acting insulin
Solution for injection, 100 IU / ml.
hypoglycemic agent - long-acting insulin analog

Solution for subcutaneous administration, 100 units / ml.

A hypoglycemic agent, a glucagon-like receptor polypeptide, an agonist

The solution for subcutaneous administration was 0.05 mg / ml (10 μg / dose) and 0.1 mg / ml (20 μg / dose).

A fully humanized monoclonal antibody (IgG1). Protein convertase inhibitor subtilisin-kexin type 9 (PCSK9)

A solution for subcutaneous administration is 75 mg / ml and 150 mg / ml.

Antimicrobial agent - fluoroquinolone

Solution for infusions 5 mg / ml.

antitumor agent - alkaloid

Concentrate for the preparation of a solution for infusions, 20 mg / 0.5 ml and 80 mg / 2 ml (complete with a solvent).

antimicrobial agent-fluoroquinolone

Tablets, film-coated 200 mg.

antimicrobial agent, fluoroquinolone.

Solution for infusion, 2 mg / ml.



(angiotensin-converting enzyme (ACE) inhibitor + blocker of "slow" calcium channels (BCCC)

Tablets of prolonged action, covered with a film membrane (2.5 mg + 2.5 mg).

Tablets of prolonged action, film-coated (5 mg + 5 mg).

For 10 or 14 tablets in a blister of PVC / aluminum foil. For 2 or 3 blisters together with instructions for use in a cardboard box.

hypoglycemic agent - long-acting insulin analog
Solution for subcutaneous administration, 300 units / ml.
local anesthetic

Solution for injection 40 mg / ml.

local anesthetic + α- and β-adrenomimetic
Solution for injection 40 mg / ml + 0.005 mg / ml, in ampoules of 2 ml and in cartridges of 1.7 ml.
local anesthetic + α- and β-adrenomimetic
Solution for injection 40 mg / ml + 0.010 mg / 1 ml.
antitumor agent - alkylating compound

Concentrate for solution for infusion, 5 mg / ml.